Craft

Advanced
Medytox

Medytox

Stock Price

₩172.6 K

2024-10-29

Market Capitalization

₩1.1 T

2024-10-29

Revenue

₩247.3 B

FY, 2025

Medytox Summary

Company Summary

Overview
Medytox is a biopharmaceutical company that focuses on the botulinum toxin industry. It offers a range of products (Neuronox, Siax, Botulift, Cunox, Acebloc, and Meditoxin) dedicated to medical aesthetics and therapeutic markets.
Type
Public
Status
Active
Founded
2000
HQ
KR | view all locations
Website
http://www.medy-tox.co.kr/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Table of Contents

LocationsView all

4 locations detected

  • Seoul HQ

    Korea (Republic of)

  • Minato City, Tokyo

    Japan

    1-chōme-10-11 Shibadaimon

  • Minato City, Tōkyō-to

    Japan

    Hamamatsu-Cho West Building, 2-chōme-10-4 Shibakōen

  • Krung Thep Maha Nakhon

    Thailand

    139 Pan Rd, Khwaeng Silom, Khet Bang Rak

Medytox Financials

Summary Financials

Revenue (FY, 2025)
₩247.3B
Gross profit (FY, 2025)
₩160.4B
Net income (FY, 2025)
₩15.7B
Cash (FY, 2025)
₩48.9B
EBIT (FY, 2025)
₩10.2B
Enterprise value
$1.2T

Competitors and Similar Companies

Compare competitors

Footer menu

Product

Solutions

Resources

Company

© Craft.co 2026
Share price data provided by IEX